Drug Margin
Previewing Reddenda Core & Pro— these are real published rates for a practice in our curated book, not your own. Add your NPI to see your RateScore.Reveal my numbers — 30 sec, no card

Every underpaid CPT on your panel, ranked in flat dollars against your local-peer median. Documented opportunity in your own data, never a guarantee.

Viewing as

Each tool shows how much of it your plan opens, next to the rows it is showing.

Core & Pro: Every row and every payer, plus the full tool set. Core and Pro see the same depth; they differ by how many NPIs you can load. Preview only. Nothing here changes an account or a price.

Drug Margin

Part B buy-and-bill

Part B buy-and-bill economics. Medicare pays the ASP payment limit (ASP + 6%) per drug; the 2% sequester trims only the Medicare-paid share. Your margin is what you net minus your acquisition cost. Enter your cost to see your real spread. Nothing is stored, no PHI.

The buy-and-bill spread

CMS sets the allowed at ASP + 6%. After the 2% sequester on the Medicare-paid portion, the net add-on lands near ASP + 4.3% at standard 20% coinsurance. You keep the spread between that and what you actually pay to acquire the drug. Commercial payers may pay more.

Your margin
Selected drug
Loading the CMS pricing file…
$

Entered here only, never stored. No PHI.

Part B drugs · highest-allowed first
Loading the CMS ASP pricing file…

Source: CMS Average Sales Price payment-limit file · public, updated quarterly · per the HCPCS billing unit shown. Medicare-based; commercial payers negotiate separately. Modeled, never a guarantee.

Book a discovery call to map this across your actual billed J-code volume and your commercial contracts, identifying the drugs where your real spread is thinnest. Unlock every CPT (the locked codes show more documented opportunity), your renewal calendar (so you fix it before the contract auto-renews), and signable leverage memos (the evidence you send the payer).

Score my panel